Revenue CAGR guidance of 25-30% for FY24-27. Revenue growth of 25% in FY25. Margins to be sustained. Outlook for next 3 years is not captured in the current valuations
Bad Q3. And the company has neither released earnings presentation nor conducting a investors call.
Most companies after IPOs somehow magically put in a bad performance after listing.
Q2 PBT growth is just 5%.
Hi Sai
Thanks for you observation. You are right.
The Q2 PBT is 5% on a standalone basis. On a consolidated basis PBT is 11%. The numbers used in our analysis is on a consolidated basis.
Even the management during the earnings was of the view that Q2 was a quarter of muted performance and is indicating to a stronger H2-25.
Please keep the comments coming. It improves the overall quality of the analysis.
We are grateful for your interest in Money Muscle.
Bad Q3. And the company has neither released earnings presentation nor conducting a investors call.
Most companies after IPOs somehow magically put in a bad performance after listing.
Q2 PBT growth is just 5%.
Hi Sai
Thanks for you observation. You are right.
The Q2 PBT is 5% on a standalone basis. On a consolidated basis PBT is 11%. The numbers used in our analysis is on a consolidated basis.
Even the management during the earnings was of the view that Q2 was a quarter of muted performance and is indicating to a stronger H2-25.
Please keep the comments coming. It improves the overall quality of the analysis.
We are grateful for your interest in Money Muscle.